Table 5. Results for univariate analysis of predictors of a pathological PFA-100 test result.
Variable | Exp(B) | 95% KI für Exp(B) | P |
All patients | |||
Age | 0.981 | 0.936–1.028 | 0.418 |
Sex | 0.900 | 0.346–2.339 | 0.829 |
MELD | 1.019 | 0.943–1.101 | 0.627 |
Albumin | 0.984 | 0.916–1.057 | 0.661 |
Platelet count | 0.992 | 0.983–1.001 | 0.086 |
Hematocrit | 0.930 | 0.864–1.001 | 0.054 |
vWF-antigen | 0.997 | 0.994–1.000 | 0.064 |
vWF-activity:vWF-antigen ratio | 13.528 | 0.409–447.335 | 0.145 |
ADAMTS13 | 0.991 | 0.967–1.014 | 0.437 |
Platelets <150/nL | |||
Age | 0.969 | 0.920–1.022 | 0.246 |
Sex | 1.161 | 0.398–3.392 | 0.785 |
MELD | 0.998 | 0.920–1.083 | 0.967 |
Albumin | 0.994 | 0.916–1.079 | 0.888 |
Platelet count | 0.990 | 0.974–1.006 | 0.223 |
Hematocrit | 0.932 | 0.860–1.010 | 0.086 |
vWF-antigen | 0.996 | 0.993–1.000 | 0.032 |
vWF-activity:vWF-antigen ratio | 17.371 | 0.309–967.333 | 0.165 |
ADAMTS13 | 0.994 | 0.969–1.019 | 0.619 |
Univariate analysis of the following variables was performed to identify predictors of a pathological PFA-100 test results in the whole study cohort and in thrombocytopenic cirrhotic patients. Multivariate analysis was then performed with variables showing a P-value ≤0.1 in univariate analysis.